Form 8-K - Current report:
SEC Accession No. 0001628280-25-044862
Filing Date
2025-10-14
Accepted
2025-10-14 08:16:36
Documents
14
Period of Report
2025-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20251010.htm   iXBRL 8-K 29525
2 EX-99.1 exhibit991-eltannouncement.htm EX-99.1 19385
6 image_0a.jpg GRAPHIC 10678
  Complete submission text file 0001628280-25-044862.txt   191122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20251010.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20251010_lab.xml EX-101.LAB 22793
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20251010_pre.xml EX-101.PRE 13042
16 EXTRACTED XBRL INSTANCE DOCUMENT gern-20251010_htm.xml XML 2809
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 251389827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)